She will move if the results are solid.. starting from a low market cap and the synergy with existing and more up to date treatments is the key.Shes tightly held and in the multi billion dollar global hcv treatment market she will offer a competitive edge.HCV/HIV are still treated by a cocktail of drugs.
BIT225 was never a stand alone treatment and the prospect of HIV trials adds a little more excitement
Shes fairly priced with a diluted market cap of $15 mil pre results but is a boom/bust play and not without risk.Nothing to do but wait.GL holders
Ann: Landmark HIV Trial Underway , page-23
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BIT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.0¢ |
Change
-0.001(4.76%) |
Mkt cap ! $18.04M | |||
| Open | High | Low | Value | Volume |
| 2.1¢ | 2.1¢ | 2.0¢ | $12.00K | 600.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 972631 | 1.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.1¢ | 199783 | 1 |
View Market Depth
| Last trade - 14.33pm 01/11/2024 (20 minute delay) ? |
| BIT (ASX) Chart |